{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:10:26Z","timestamp":1780539026121,"version":"3.54.1"},"reference-count":47,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI18\/00383"],"award-info":[{"award-number":["PI18\/00383"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI21\/0555"],"award-info":[{"award-number":["PI21\/0555"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["PI18\/00383"],"award-info":[{"award-number":["PI18\/00383"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["PI21\/0555"],"award-info":[{"award-number":["PI21\/0555"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007509","name":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022302","name":"Societat Catalana de Pneumologia","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100022302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,9,10]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary hypertension (PH) associated with lung disease entails a poor prognosis. There is concern about the potential deleterious effect on gas exchange of drugs approved for pulmonary arterial hypertension (PAH) in patients with lung disease. We conducted a systematic review on the effects of drugs approved for PAH on arterial oxygenation in randomised clinical trials (RCTs) conducted in patients with PH associated with lung disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Five databases were searched until May 2025. We included RCTs with PAH therapies in patients with PH associated with lung disease that reported measurements of arterial oxygenation, either the partial pressure of arterial oxygen (PaO\n                      <jats:sub>2<\/jats:sub>\n                      ) or the arterial oxygen saturation (SpO\n                      <jats:sub>2<\/jats:sub>\n                      ). For analysis purposes, both measurements were merged into one single variable called \u2018overall oxygenation\u2019. As secondary outcomes, we analysed the use of supplemental oxygen and the presence of adverse events related to oxygenation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 393 reports returned by the initial search, nine articles, reporting 827 patients (64.6% male), were included. The overall oxygenation at the end of the trial in the intervention group (IG), treated with a PAH therapy, was similar to the control group (standard mean difference (SMD) \u22120.00; 95%\u2009CI \u22120.17 to 0.18; p=0.98). Similarly, the change in overall oxygenation postintervention in the IG was similar to the control group (SMD 0.01; 95%\u2009CI \u22120.22 to 0.24; p=0.91). Reported adverse events related to oxygenation were similar in the treatment and control arms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is currently no consistent evidence from RCTs to suggest a deleterious effect of PAH therapies on arterial oxygenation in patients with PH associated with lung disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42022349299.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-003086","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:50:49Z","timestamp":1760093449000},"page":"e003086","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of pulmonary arterial hypertension therapies on arterial oxygenation in patients with pulmonary hypertension associated with lung disease: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9452-3432","authenticated-orcid":false,"given":"Isabel","family":"Blanco","sequence":"first","affiliation":[{"name":"Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Fundacio de Recerca Cl\u00ednic Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Torres-Castro","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, University of Barcelona, Barcelona, Spain"},{"name":"Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Piccari","sequence":"additional","affiliation":[{"name":"Pulmonology, Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn Roberto","family":"Garcia","sequence":"additional","affiliation":[{"name":"Fundacio de Recerca Cl\u00ednic Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, Spain"},{"name":"Department of Pulmonary Medicine, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gimeno-Santos","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, University of Barcelona, Barcelona, Spain"},{"name":"Instituto de Salud Global, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Fundacio de Recerca Cl\u00ednic Barcelona, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, Spain"},{"name":"Department of Pulmonary Medicine, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Albert","family":"Barber\u00e0","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, University of Barcelona, Barcelona, Spain"},{"name":"Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"2026010701514383000_12.1.e003086.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01914-2018"},{"key":"2026010701514383000_12.1.e003086.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.02.016"},{"key":"2026010701514383000_12.1.e003086.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00079512"},{"key":"2026010701514383000_12.1.e003086.4","doi-asserted-by":"crossref","DOI":"10.1177\/2045894021999960","article-title":"Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database","volume":"11","author":"Nathan","year":"2021","journal-title":"Pulm Circ"},{"key":"2026010701514383000_12.1.e003086.5","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/COPD.S359873","article-title":"The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026010701514383000_12.1.e003086.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"2026010701514383000_12.1.e003086.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200401-006OC"},{"key":"2026010701514383000_12.1.e003086.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.11.020"},{"key":"2026010701514383000_12.1.e003086.9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0820"},{"key":"2026010701514383000_12.1.e003086.10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0043-1770121","article-title":"Management of Pulmonary Hypertension Associated with Chronic Lung Disease","volume":"44","author":"Blanco","year":"2023","journal-title":"Semin Respir Crit Care Med"},{"key":"2026010701514383000_12.1.e003086.11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02897-2021"},{"key":"2026010701514383000_12.1.e003086.12","doi-asserted-by":"publisher","DOI":"10.1086\/681264"},{"key":"2026010701514383000_12.1.e003086.13","doi-asserted-by":"crossref","first-page":"107585","DOI":"10.1016\/j.rmed.2024.107585","article-title":"Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype","volume":"225","author":"Steger","year":"2024","journal-title":"Respir Med"},{"key":"2026010701514383000_12.1.e003086.14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chest.2024.08.016","article-title":"Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry","volume":"167","author":"Tello","year":"2025","journal-title":"Chest"},{"key":"2026010701514383000_12.1.e003086.15","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220821"},{"key":"2026010701514383000_12.1.e003086.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200907-0988OC"},{"key":"2026010701514383000_12.1.e003086.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198106253042606"},{"key":"2026010701514383000_12.1.e003086.18","first-page":"612","article-title":"Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease","volume":"130","author":"Melot","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2026010701514383000_12.1.e003086.19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1086\/680214","article-title":"Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease","volume":"5","author":"Ghofrani","year":"2015","journal-title":"Pulm Circ"},{"key":"2026010701514383000_12.1.e003086.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052248","article-title":"Acute effects of aerosolized iloprost in COPD related pulmonary hypertension - a randomized controlled crossover trial","volume":"7","author":"Boeck","year":"2012","journal-title":"PLoS One"},{"key":"2026010701514383000_12.1.e003086.21","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01104.2010"},{"key":"2026010701514383000_12.1.e003086.22","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.9810008"},{"key":"2026010701514383000_12.1.e003086.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11024-5"},{"key":"2026010701514383000_12.1.e003086.24","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-015-0574-9","article-title":"Management of Pulmonary Hypertension in Patients with Chronic Lung Disease","volume":"17","author":"Barber\u00e0","year":"2015","journal-title":"Curr Hypertens Rep"},{"key":"2026010701514383000_12.1.e003086.25","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14979"},{"key":"2026010701514383000_12.1.e003086.26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"2026010701514383000_12.1.e003086.27","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"2026010701514383000_12.1.e003086.28","doi-asserted-by":"crossref","unstructured":"Higgins J , Thomas J , Chandler J , et al . Cochrane handbook for systematic reviews of interventions version 6.0. 2019.","DOI":"10.1002\/9781119536604"},{"key":"2026010701514383000_12.1.e003086.29","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00011308"},{"key":"2026010701514383000_12.1.e003086.30","doi-asserted-by":"publisher","DOI":"10.1177\/1753465808103499"},{"key":"2026010701514383000_12.1.e003086.31","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00176312"},{"key":"2026010701514383000_12.1.e003086.32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0446OC"},{"key":"2026010701514383000_12.1.e003086.33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-2600(14)70013-X","article-title":"Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial","volume":"2","author":"Goudie","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026010701514383000_12.1.e003086.34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2016.04.010","article-title":"Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial","volume":"36","author":"Vitulo","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2026010701514383000_12.1.e003086.35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S2213-2600(19)30250-4","article-title":"Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study","volume":"7","author":"Nathan","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026010701514383000_12.1.e003086.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008470"},{"key":"2026010701514383000_12.1.e003086.37","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12043","article-title":"Tadalafil for veterans with chronic obstructive pulmonary disease\u2014pulmonary hypertension: A multicenter, placebo\u2010controlled randomized trial","volume":"12","author":"Maron","year":"2022","journal-title":"Pulm circ"},{"key":"2026010701514383000_12.1.e003086.38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1513\/AnnalsATS.201710-762OC","article-title":"Phosphodiesterase-5 Inhibitor Therapy for Pulmonary Hypertension in the United States. Actual versus Recommended Use","volume":"15","author":"Kim","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2026010701514383000_12.1.e003086.39","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2147\/COPD.S141798","article-title":"Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension","volume":"12","author":"Wang","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026010701514383000_12.1.e003086.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2009.04.002"},{"key":"2026010701514383000_12.1.e003086.41","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.4.289"},{"key":"2026010701514383000_12.1.e003086.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2006.01.013"},{"key":"2026010701514383000_12.1.e003086.43","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15016"},{"key":"2026010701514383000_12.1.e003086.44","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00463-2023"},{"key":"2026010701514383000_12.1.e003086.45","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-9-201305070-00003"},{"key":"2026010701514383000_12.1.e003086.46","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00172-2024"},{"key":"2026010701514383000_12.1.e003086.47","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv317"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-003086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:53:07Z","timestamp":1767779587000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-003086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,10]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/bmjresp-2024-003086"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-003086","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}